Abstract
The oral delivery of therapeutics is of paramount importance to medical application and advancement. There has been remarkable advancement in the field of polymeric formulations for oral delivery of therapeutics. Novel polymeric formulation like polymeric nanoparticles, micelles and dendrimers are exploited and researched to further improve the bioavailability, stability, permeability and therapeutic efficacy. Over the last years, there have been number of approaches used for the effective delivery of bioactive(s). These include chemical modification, use of enzyme inhibitors and permeation enhancers, and novel drug delivery systems. Numerous polymeric nanoarchitectures based strategies are able to overcome restrictions and show the promising approach for efficient [P/P] drugs oral delivery. The aim of present review focuses on the need for the development of polymeric nanocarrier for oral-peptide and protein delivery with emphases on insulin delivery via various polymeric nanocarriers.
Keywords: Caco-2 cell monolayers, dendrimers, nanoparticles, oral delivery.
Current Drug Therapy
Title:Polymeric Nanocarriers for the Oral Delivery of Bioactives
Volume: 9 Issue: 1
Author(s): Rajeev Sharma, Udita Agrawal and Suresh P. Vyas
Affiliation:
Keywords: Caco-2 cell monolayers, dendrimers, nanoparticles, oral delivery.
Abstract: The oral delivery of therapeutics is of paramount importance to medical application and advancement. There has been remarkable advancement in the field of polymeric formulations for oral delivery of therapeutics. Novel polymeric formulation like polymeric nanoparticles, micelles and dendrimers are exploited and researched to further improve the bioavailability, stability, permeability and therapeutic efficacy. Over the last years, there have been number of approaches used for the effective delivery of bioactive(s). These include chemical modification, use of enzyme inhibitors and permeation enhancers, and novel drug delivery systems. Numerous polymeric nanoarchitectures based strategies are able to overcome restrictions and show the promising approach for efficient [P/P] drugs oral delivery. The aim of present review focuses on the need for the development of polymeric nanocarrier for oral-peptide and protein delivery with emphases on insulin delivery via various polymeric nanocarriers.
Export Options
About this article
Cite this article as:
Sharma Rajeev, Agrawal Udita and Vyas P. Suresh, Polymeric Nanocarriers for the Oral Delivery of Bioactives, Current Drug Therapy 2014; 9 (1) . https://dx.doi.org/10.2174/1574885509666140805004615
DOI https://dx.doi.org/10.2174/1574885509666140805004615 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |
Call for Papers in Thematic Issues
Novel Therapeutic Approaches and Biomarkers for Chronic Kidney Disease (CKD)
The thematic issue on "Novel Therapeutic Approaches and Biomarkers for CKD" aims to provide a comprehensive exploration of cutting-edge strategies for the management of chronic kidney disease (CKD). This issue will delve into emerging therapeutic targets, focusing on critical aspects such as podocyte injury, endothelial dysfunction, and tubulointerstitial fibrosis, which ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pulmonary Embolism Response Team (PERT) - A New Paradigm for the Treatment
of Pulmonary Embolism
Current Pharmaceutical Design Refolding Additive, Dimethylbenzylammonium Propane Sulfonate (NDSB- 256), Accelerates Gly-Pro cis-trans Isomerization
Protein & Peptide Letters Melanoma Immunotherapy: Past, Present, and Future
Current Pharmaceutical Design Micro-/nano-electroporation for active gene delivery
Current Pharmaceutical Design MicroRNAs for Diagnosis and Treatment of Colorectal Cancer
Endocrine, Metabolic & Immune Disorders - Drug Targets Synergistic Extraction of Zn2+ from Aqueous Buffer Medium of Chloride Ions into 1- Phenyl -3- Methyl -4- Trichloro Acetyl Pyrazolone - 5 in Benzene and Hexane
Recent Patents on Materials Science Is Effective and Safe a Radiochemotherapy Approach in Elderly Cancer Patients? A Review
Anti-Cancer Agents in Medicinal Chemistry Neurobiological Mechanisms of Stress Resilience and Implications for the Aged Population
Current Neuropharmacology Clinical Review of COVID-19; Pathogenesis, Diagnosis, and Management
Current Pharmaceutical Design Targeting ErbB Receptors in High-Grade Glioma
Current Pharmaceutical Design Promoting Inter-/Intra- Cellular Process of Nanomedicine through its Physicochemical Properties Optimization
Current Drug Metabolism Synthesis, Molecular Docking and Pharmacological Study of Pyrimidothiadiazinones and its bis-derivatives
Letters in Drug Design & Discovery Tyrosinase Electrochemical Biosensors Monitoring Medicinally Significant Substances
Current Medicinal Chemistry Flow-Injection Potentiometric Method for the Routine Determination of Chloride: Application to Bread Analysis
Current Analytical Chemistry Acafusin, a Dimeric Antifungal Protein from Acacia confusa Seeds
Protein & Peptide Letters An Ion Mobility Assisted Data Independent LC-MS Strategy for the Analysis of Complex Biological Samples
Current Analytical Chemistry Synthesis, Evaluation and Molecular Docking Studies of 1,3,4-oxadiazole- 2-thiol Incorporating Fatty Acid Moiety as Antitumor and Antimicrobial Agents
Letters in Drug Design & Discovery Metabolomics of Medicinal Plants: The Importance of Multivariate Analysis of Analytical Chemistry Data
Current Computer-Aided Drug Design Design and Synthesis of Mannich bases as Benzimidazole Derivatives as Analgesic Agents
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Synthesis and Biological Evaluation of Novel 1,3,4-thiadiazole Derivatives Incorporating Benzisoselenazolone Scaffold as Potential Antitumor Agents
Medicinal Chemistry